EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Exploring the Potential of Wharton’s Jelly-Derived Mesenchymal Stem Cells as a Therapeutic Approach for Preterm Premature Rupture of Membranes

Hyeongseop Kim iD, Hyunju Kim iD, Suyeon Jeon iD, Soo-Young Oh iD, Sang Eon Park iD, Hong Bae Jeon iD, Jung-Sun Kim iD, Suk-Joo Choi iD, Jong Wook Chang iD

International Journal of Stem Cells · 30.05.2026 · 19 (2) · 212-223

DOI: 10.15283/ijsc25048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Stem Cells, online erschienen am 11.03.2026. Verfasst von Hyeongseop Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Development Division, ENCell Co., Ltd., Seoul, Korea. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare, Samsung Medical Center, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cell- and tissue-based therapyMesenchymal stem cellsPremature rupture of fetal membranesRegenerative medicineWound healing

Autor:innen und Institutionen

  • New Drug Development Division, ENCell Co., Ltd., Seoul, Korea.
  • Cell & Gene Therapy Institute, Samsung Medical Center, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.

ORCID-Profile: Hyeongseop Kim, Hyunju Kim, Suyeon Jeon, Soo-Young Oh, Sang Eon Park, Hong Bae Jeon, Jung-Sun Kim, Suk-Joo Choi, Jong Wook Chang

Förderung

  • Ministry of Health and Welfare
  • Samsung Medical Center
  • Korea Health Industry Development Institute

Zitieren

APA

Kim, H., Kim, H., Jeon, S., Oh, S. Y., Park, S. E., Jeon, H. B., Kim, J. S., Choi, S. J., & Chang, J. W. (2026). Exploring the Potential of Wharton’s Jelly-Derived Mesenchymal Stem Cells as a Therapeutic Approach for Preterm Premature Rupture of Membranes. International Journal of Stem Cells, 19(2), 212-223. https://doi.org/10.15283/ijsc25048

Vancouver

Kim H, Kim H, Jeon S, Oh SY, Park SE, Jeon HB, et al. Exploring the Potential of Wharton’s Jelly-Derived Mesenchymal Stem Cells as a Therapeutic Approach for Preterm Premature Rupture of Membranes. International Journal of Stem Cells. 2026;19(2):212-223. doi:10.15283/ijsc25048

BibTeX
@article{Kim2026,
  author = {Kim, Hyeongseop and Kim, Hyunju and Jeon, Suyeon and Oh, Soo-Young and Park, Sang Eon and Jeon, Hong Bae and Kim, Jung-Sun and Choi, Suk-Joo and Chang, Jong Wook},
  title = {Exploring the Potential of Wharton’s Jelly-Derived Mesenchymal Stem Cells as a Therapeutic Approach for Preterm Premature Rupture of Membranes},
  journal = {International Journal of Stem Cells},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {212--223},
  doi = {10.15283/ijsc25048}
}
Kostenlos starten →